Celiac Disease Market, By Treatment (Infliximab, Larazotide Acetate, and Gluten Free Diet), By Disease Type, By Distribution Channel, By Route of Administration, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5204
|
Published Date
May 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Celiac Disease Market size was valued at US$ 967.83 Million in 2025, expanding at a CAGR of 10.34% from 2026 to 2033.
Celiac disease is a long-term autoimmune digestive disorder in which the body reacts abnormally to gluten found in wheat, barley, and rye. Gluten consumption damages the small intestine, leading to impaired nutrient absorption. Common symptoms include abdominal pain, diarrhea, fatigue, anemia, and weight loss. Management primarily involves strict adherence to a gluten-free diet along with regular medical monitoring.
The celiac disease market focuses on the diagnosis, treatment, and long-term management of this gluten-related autoimmune condition affecting the small intestine. Globally, the market is gaining increasing attention due to rising diagnosis rates and stronger public health initiatives. However, as noted by organizations such as the World Health Organization and the National Institutes of Health, a significant number of cases remain undiagnosed due to symptom overlap with other gastrointestinal disorders. Countries such as India, Italy, and Canada are increasing awareness through national screening initiatives, gastroenterology programs, and food safety regulations. This growing focus on early detection, combined with improved diagnostic technologies and the expanding availability of gluten-free food standards, is supporting steady development of the global celiac disease healthcare ecosystem.
Celiac Disease Market- Market Dynamics
Increasing awareness of gluten-related digestive disorders driving earlier diagnosis and improved disease detection
Rising awareness of gluten-related digestive disorders is playing an important role in supporting earlier diagnosis of celiac disease. As individuals become more informed about symptoms such as fatigue, abdominal discomfort, and nutrient deficiencies, they are increasingly likely to seek medical evaluation at an earlier stage. This has contributed to greater use of blood-based screening tests and biopsy procedures in clinical practice, enabling healthcare professionals to identify the condition before significant intestinal damage occurs.
Health agencies such as the National Institutes of Health emphasize the importance of awareness, as many cases remain undiagnosed due to symptom overlap with other gastrointestinal disorders. Similarly, the World Health Organization promotes global awareness among patients and healthcare providers regarding autoimmune and diet-related conditions to improve digestive health outcomes worldwide. These efforts have supported the development of improved diagnostic tools and reinforced guidance on gluten-free dietary management, contributing to better disease recognition and patient care.
Celiac Disease Market- Segmentation Analysis:
The Global Celiac Disease Market is segmented on the basis of Treatment, Disease Type, Distribution Channel, Route of Administration, End User, and Region.
Under the route of administration, the market is divided into two main types. Among these, oral formulations are expected to account for a significant share due to their convenience in long-term dietary and therapeutic management. Individuals managing autoimmune digestive disorders often prefer easy-to-use treatment options and nutritional supplements that can be incorporated into daily routines without clinical supervision. Healthcare providers and research organizations are also increasingly focusing on oral investigational therapies aimed at improving intestinal health and reducing gluten-triggered immune responses. Companies such as Takeda Pharmaceutical Company and Anokion SA are actively engaged in clinical research related to oral celiac disease therapies and immune tolerance approaches. In addition, the growing availability of oral gluten-free nutritional products and supplements is supporting wider acceptance of non-invasive management strategies among patients and healthcare professionals.
In terms of disease types, the market is segmented into Classical Celiac Disease, Non-Classical Celiac Disease, Silent Celiac Disease, Refractory Celiac Disease, and Potential Celiac Disease. Among these, classical celiac disease holds a prominent position, as patients typically present with noticeable gastrointestinal symptoms such as chronic diarrhea, abdominal discomfort, weight loss, and impaired nutrient absorption. These clear clinical manifestations often lead to earlier physician consultation and diagnostic testing compared to less symptomatic forms of the disease. Healthcare organizations are also increasing awareness of gastrointestinal autoimmune disorders to support timely diagnosis and dietary management. The National Institutes of Health notes that untreated celiac disease can lead to nutritional deficiencies and intestinal complications, reinforcing the need for early detection. Companies such as Thermo Fisher Scientific and Bio-Rad Laboratories are expanding diagnostic capabilities for autoimmune digestive conditions. Growing awareness of digestive health and gluten sensitivity is further supporting clinical engagement in the management of classical celiac disease cases.
Celiac Disease Market- Geographical Insights
Across the Asia Pacific, healthcare systems are gradually strengthening awareness, diagnosis, and nutritional management practices associated with celiac disease, creating supportive conditions for continued market growth. Governments and healthcare organizations in the region are promoting food labeling transparency, digestive disorder screening, and wider availability of gluten-free nutritional products to improve patient care outcomes. Research published in Scientific Reports indicates that celiac disease prevalence across several Asia Pacific countries is being increasingly recognized due to improved clinical testing and expanding public health awareness initiatives. In India, the food regulatory framework established by the Food Safety and Standards Authority of India supports gluten-free food labeling and standardization, helping individuals with gluten intolerance make safer dietary choices. Government-led awareness programs and expanding gastroenterology services are also supporting earlier diagnosis and improved dietary counseling.
From an industry perspective, organizations such as Nestlé Health Science, Takeda Pharmaceutical Company, and Dr. Schär are actively involved in gluten-free nutrition, gastroenterology-focused products, and research into therapies for autoimmune digestive disorders. This combination of regulatory support, clinical awareness, nutritional innovation, and industry participation is contributing to improved management of celiac disease across the Asia Pacific region.
Japan Celiac Disease Market- Country Insights
Japan is gradually increasing healthcare awareness related to celiac disease and gluten-sensitive digestive conditions through improved food labeling guidance, nutritional monitoring, and specialized dietary support initiatives. Japanese authorities and food safety organizations are promoting accurate allergen labeling and safer food manufacturing practices to support individuals requiring gluten-restricted diets. In addition, government-led initiatives are working toward developing standards for non-gluten rice flour products to enhance food labeling consistency and export quality. Organizations such as Nestlé Health Science and SGS Japan are collaborating on gluten-free nutrition and certification programs.
Japan is also witnessing growing industry participation aimed at improving food accessibility for individuals with celiac disease. Government-supervised food labeling practices for packaged products have enhanced transparency in ingredient disclosure and consumer safety. At the same time, increasing awareness of gluten-free diets through health education programs and nutritional counseling by healthcare providers is contributing to improved understanding and management of celiac disease in the country.
Celiac Disease Market- Competitive Landscape:
The celiac disease market is shaped by the active participation of pharmaceutical companies, nutrition providers, diagnostic organizations, and biotechnology firms focused on managing autoimmune digestive disorders and gluten-related health conditions. Industry developments are driven by innovations in gluten-free nutritional products, investigational therapies, advanced diagnostics, and immunotherapy approaches aimed at improving long-term disease management and patient quality of life. Key companies strengthening their presence in this space include Takeda Pharmaceutical Company, Nestlé Health Science, Anokion SA, Barinthus Biotherapeutics, and Evaxion Biotech. In 2025, Takeda continued advancing investigational therapies targeting gluten-triggered immune responses, while Anokion expanded clinical evaluation programs for KAN-101 to support antigen-specific immune tolerance research. Increasing awareness of digestive health, gluten sensitivity diagnosis, and dietary support solutions is further driving broader healthcare engagement and therapeutic development in the celiac disease field.
Recent Developments
- In November 2025, 9 Meters Biopharma continued research on larazotide acetate, an investigational therapy aimed at improving intestinal barrier function in patients with celiac disease. The program supports efforts to explore treatment options beyond gluten-free dietary management.
- In August 2025, Dr. Schär expanded its portfolio with additional gluten-free food products designed for individuals managing celiac disease-related dietary restrictions, improving global availability of specialized nutritional options.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELIAC DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Sanofi
- Novartis AG
- Amgen Inc.
- Anokion SA
- Barinthus Biotherapeutics
- Topas Therapeutics GmbH
- Entero Therapeutics, Inc.
- Equillium, Inc.
- Chugai Pharmaceutical Co., Ltd.
- Immunic Therapeutics
- Mozart Therapeutics Australia Pty Ltd
- AMYRA Biotech AG
- Calypso Biotech
- Forte Biosciences, Inc.
- Hoffmann-La Roche Ltd.
- Parvus Therapeutics
- BioLineRx Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals PLC
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Nestlé Health Science
- Others
GLOBAL CELIAC DISEASE MARKET, BY TREATMENT - MARKET ANALYSIS, 2020 - 2033
- Infliximab
- Larazotide Acetate
- Clinical Trial Phase Products
- Oral Capsule Formulation
- Adult Celiac Patients
- Pediatric Investigational Use
- Monotherapy and Combination Therapy
- Gluten Free Diet
- Packaged Gluten-Free Foods
- Gluten-Free Bakery Products
- Gluten-Free Snacks
- Gluten-Free Nutritional Supplements
- Gluten-Free Beverages
- Others
- Corticosteroids
- Immunosuppressive Drugs
- Enzyme Therapies
- Monoclonal Antibodies
- Probiotics and Microbiome Modulators
GLOBAL CELIAC DISEASE MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020 - 2033
- Classical Celiac Disease
- Non-Classical Celiac Disease
- Silent Celiac Disease
- Refractory Celiac Disease
- Potential Celiac Disease
GLOBAL CELIAC DISEASE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others
GLOBAL CELIAC DISEASE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Oral
- Parenteral
GLOBAL CELIAC DISEASE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Homecare
- Others
GLOBAL CELIAC DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Celiac Disease Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Celiac Disease Market Snippet by Treatment
2.1.2. Celiac Disease Market Snippet by Disease Type
2.1.3. Celiac Disease Market Snippet by Distribution Channel
2.1.4. Celiac Disease Market Snippet by Route of Administration
2.1.5. Celiac Disease Market Snippet by End User
2.1.6. Celiac Disease Market Snippet by Country
2.1.7. Celiac Disease Market Snippet by Region
2.2. Competitive Insights
3. Celiac Disease Key Market Trends
3.1. Celiac Disease Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Celiac Disease Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Celiac Disease Market Opportunities
3.4. Celiac Disease Market Future Trends
4. Celiac Disease Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Celiac Disease Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Celiac Disease Market Landscape
6.1. Celiac Disease Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Celiac Disease Market – By Disease Type
7.1. Overview
7.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
7.1.2. Classical Celiac Disease
7.1.3. Non-Classical Celiac Disease
7.1.4. Silent Celiac Disease
7.1.5. Refractory Celiac Disease
7.1.6. Potential Celiac Disease
8. Celiac Disease Market – By Distribution Channel
8.1. Overview
8.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
8.1.2. Hospital Pharmacy
8.1.3. Online Pharmacy
8.1.4. Retail Pharmacy
8.1.5. Others
9. Celiac Disease Market – By Treatment
9.1. Overview
9.1.1. Segment Share Analysis, By Treatment, 2025 & 2033 (%)
9.1.2. Infliximab
9.1.3. Larazotide Acetate
9.1.3.1. Clinical Trial Phase Products
9.1.3.2. Oral Capsule Formulation
9.1.3.3. Adult Celiac Patients
9.1.3.4. Pediatric Investigational Use
9.1.3.5. Monotherapy and Combination Therapy
9.1.4. Gluten Free Diet
9.1.4.1. Packaged Gluten-Free Foods
9.1.4.2. Gluten-Free Bakery Products
9.1.4.3. Gluten-Free Snacks
9.1.4.4. Gluten-Free Nutritional Supplements
9.1.4.5. Gluten-Free Beverages
9.1.5. Others
9.1.5.1. Corticosteroids
9.1.5.2. Immunosuppressive Drugs
9.1.5.3. Enzyme Therapies
9.1.5.4. Monoclonal Antibodies
10. Celiac Disease Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
10.1.2. Oral
10.1.3. Parenteral
11. Celiac Disease Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Hospitals
11.1.3. Homecare
11.1.4. Others
12. Celiac Disease Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Celiac Disease Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Celiac Disease Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Celiac Disease Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Celiac Disease Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Celiac Disease Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Celiac Disease Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Takeda Pharmaceutical Company Limited
13.2.2. Teva Pharmaceutical Industries Ltd.
13.2.3. Pfizer Inc.
13.2.4. Sanofi
13.2.5. Novartis AG
13.2.6. Amgen Inc.
13.2.7. Anokion SA
13.2.8. Barinthus Biotherapeutics
13.2.9. Topas Therapeutics GmbH
13.2.10. Entero Therapeutics, Inc.
13.2.11. Equillium, Inc.
13.2.12. Chugai Pharmaceutical Co., Ltd.
13.2.13. Immunic Therapeutics
13.2.14. Mozart Therapeutics Australia Pty Ltd
13.2.15. AMYRA Biotech AG
13.2.16. Calypso Biotech
13.2.17. Forte Biosciences, Inc.
13.2.18. Hoffmann-La Roche Ltd.
13.2.19. Parvus Therapeutics
13.2.20. BioLineRx Ltd.
13.2.21. Glenmark Pharmaceuticals Ltd.
13.2.22. Hikma Pharmaceuticals PLC
13.2.23. Thermo Fisher Scientific Inc.
13.2.24. Bio-Rad Laboratories, Inc.
13.2.25. Nestlé Health Science
13.2.26. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELIAC DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Sanofi
- Novartis AG
- Amgen Inc.
- Anokion SA
- Barinthus Biotherapeutics
- Topas Therapeutics GmbH
- Entero Therapeutics, Inc.
- Equillium, Inc.
- Chugai Pharmaceutical Co., Ltd.
- Immunic Therapeutics
- Mozart Therapeutics Australia Pty Ltd
- AMYRA Biotech AG
- Calypso Biotech
- Forte Biosciences, Inc.
- Hoffmann-La Roche Ltd.
- Parvus Therapeutics
- BioLineRx Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals PLC
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Nestlé Health Science
- Others
GLOBAL CELIAC DISEASE MARKET, BY TREATMENT - MARKET ANALYSIS, 2020 - 2033
- Infliximab
- Larazotide Acetate
- Clinical Trial Phase Products
- Oral Capsule Formulation
- Adult Celiac Patients
- Pediatric Investigational Use
- Monotherapy and Combination Therapy
- Gluten Free Diet
- Packaged Gluten-Free Foods
- Gluten-Free Bakery Products
- Gluten-Free Snacks
- Gluten-Free Nutritional Supplements
- Gluten-Free Beverages
- Others
- Corticosteroids
- Immunosuppressive Drugs
- Enzyme Therapies
- Monoclonal Antibodies
- Probiotics and Microbiome Modulators
GLOBAL CELIAC DISEASE MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020 - 2033
- Classical Celiac Disease
- Non-Classical Celiac Disease
- Silent Celiac Disease
- Refractory Celiac Disease
- Potential Celiac Disease
GLOBAL CELIAC DISEASE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others
GLOBAL CELIAC DISEASE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Oral
- Parenteral
GLOBAL CELIAC DISEASE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Homecare
- Others
GLOBAL CELIAC DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
